Search

 
 
 
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOS & More

BIOTECH ROUNDUP: OPIOID NEWS, ASH PREVIEW, BOSTON BIO IPOS & MORE

The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump's opioid commission...

States investigate pharma companies, CVS Health as diabetes drug prices reach record highs

STATES INVESTIGATE PHARMA COMPANIES, CVS HEALTH AS DIABETES DRUG PRICES REACH RECORD HIGHS

The United States is one of the few developed countries without regulations on prescription drug pricing.

 
 
 
Terminated Blood Cancer Drug Springs Back to Life at SD Biotech

TERMINATED BLOOD CANCER DRUG SPRINGS BACK TO LIFE AT SD BIOTECH

A blood cancer drug resurrected by the scientist who helped discover the compound, and who shepherded it through years of R&D, got...

Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact

ELI LILLY TO PURSUE MRNA CANCER VACCINES WITH CUREVAC PACT

Eli Lilly is getting a foothold in messenger RNA cancer vaccines through a deal with CureVac that could develop up to five new therapies....

 
 
 
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More

BIO ROUNDUP: GRAHAM-CASSIDY, AXOVANT FAIL, SPRINGWORKS LAUNCHES & MORE

After drug pricing, count drug shortages among the hot button issues sparking patient ire. Last year, the FDA says, 23 drug shortages...

 
 
 
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing

REGENERON TOUTS SUCCESS IN BIG ASTHMA DRUG STUDY, PLANS FDA FILING

A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron...

 
 
 

AXXAM SRL ENTERS INTO RESEARCH COLLABORATION WITH SANOFI IN THE FIELD OF NEURODEGENERATION

Life Sciences Jobs ...

 
 
 
 
 
 
 
 
 
FDA green lights Sanofi and Regeneron's new RA therapy

FDA GREEN LIGHTS SANOFI AND REGENERON'S NEW RA THERAPY

With a list price 30% lower than the top TNF-alpha inhibitors, Regeneron and Sanofi hope to rapidly capture significant market share...

Larger-than-life biotech figure Henri Termeer dies at 71

LARGER-THAN-LIFE BIOTECH FIGURE HENRI TERMEER DIES AT 71

A shining light for the biotechnology industry, for Kendall Square, and for patients with rare diseases has passed away. Henri Termeer...

 
 
 
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer

BIO LEADERS MOURN PASSING OF GENZYME EXEC, ORPHAN DRUG INNOVATOR TERMEER

Henri Termeer, a biotechnology pioneer and the longtime CEO of Genzyme, has passed away at the age of 71. According to the Boston Globe...